Browse > Article
http://dx.doi.org/10.11001/jksww.2019.33.6.469

Degradation of residual pharmaceuticals in water by UV/H2O2 advanced oxidation process  

Park, Chinyoung (Water Quality Institute, Waterworks Headquarter Incheon Metropolitan City)
Seo, Sangwon (Marine Research Team, Incheon Health Environment Research Institute)
Cho, Ikhwan (Water Quality Institute, Waterworks Headquarter Incheon Metropolitan City)
Jun, Yongsung (Water Quality Institute, Waterworks Headquarter Incheon Metropolitan City)
Ha, Hyunsup (Water Quality Institute, Waterworks Headquarter Incheon Metropolitan City)
Hwang, Tae-Mun (The Department of Land, Water and Environment Research, Korea Institute of Civil Engineering and Building Technology)
Publication Information
Journal of Korean Society of Water and Wastewater / v.33, no.6, 2019 , pp. 469-480 More about this Journal
Abstract
This study was conducted to evaluate the degradation and mineralization of PPCPs (Pharmaceuticals and Personal Care Products) using a CBD(Collimated Beam Device) of UV/H2O2 advanced oxidation process. The decomposition rate of each substance was regarded as the first reaction rate to the ultraviolet irradiation dose. The decomposition rate constants for PPCPs were determined by the concentration of hydrogen peroxide and ultraviolet irradiation intensity. If the decomposition rate constant is large, the PPCPs concentration decreases rapidly. According to the decomposition rate constant, chlortetracycline and sulfamethoxazole are expected to be sufficiently removed by UV irradiation only without the addition of hydrogen peroxide. In the case of carbamazepine, however, very high UV dose was required in the absence of hydrogen peroxide. Other PPCPs required an appropriate concentration of hydrogen peroxide and ultraviolet irradiation intensity. The UV dose required to remove 90% of each PPCPs using the degradation rate constant can be calculated according to the concentration of hydrogen peroxide in each sample. Using this reaction rate, the optimum UV dose and hydrogen peroxide concentration for achieving the target removal rate can be obtained by the target PPCPs and water properties. It can be a necessary data to establish design and operating conditions such as UV lamp type, quantity and hydrogen peroxide concentration depending on the residence time for the most economical operation.
Keywords
Ultraviolet; Advanced oxidation process; Pharmaceuticals; Hydrogen peroxide; UV dose;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Khiari, D. (2007). Endocrine disruptors, pharmaceuticals, and personal care products in drinking water: an overview of AwwaRF research to date, Denver, CO, Awwa Research Foundation.
2 Kim, S.D., Cho, J., Kim, I.S., Vanderford, B.J. and Snyder, S.A. (2007). Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking and waste waters, Water Res., 41, 1013-1021.   DOI
3 Moldovan. Z. (2006). Occurrences of pharmaceutical and personal care products as micropollutants in rivers from Romania, Chemosphere, 64, 1808-1817.   DOI
4 Pereira, V.J., Linden, K.G. and Weinberg, H.S. (2007). Evaluation of UV irradiation for photolytic and oxidative degradation of pharmaceutical compounds in water, Water Res., 41(19), 4413-4423.   DOI
5 Seo, H.J., Park, Y.H., Kang, I.S., Myong, H.B., Song, Y.S. and Kang, Y.J. (2016). Evaluation on the removal efficiency of pharmaceutical compounds in conventional drinking water treatment processes, Anal. Sci. Technol., 29, 126-135.   DOI
6 Shin, H.S. (2011). The study of investigation and analysis of residual pharmaceuticals, National institute of Environmental Research.
7 Snyder, S.A., Westerhoff, P,, Yoon Y. and Sedlak, D.L. (2003). Pharmaceuticals, personal care products and endocrine disruptors in water: implications for the water industry, Environ. Eng. Sci., 20, 449-469.   DOI
8 Ternes TA, Stuber J, Hermann N, Ried A, Kampmann M, and Teiser B. (2003). Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater?, Water Res., 37. 1976-1982.   DOI
9 US EPA. (2006). Ultraviolet disinfection guidance manual for the final long term 2 enhanced suraced water treatment rule, C-1.
10 Zwiener C. and Frimmel F.H. (2000). Oxidative treatment of pharmaceuticals in water, Water Res., 34(6). 1881-1885.   DOI
11 Adams, C., ASCE, M., Wang, Y., Loftine, K. and Meyer, M., (2002). Removal of antibiotics from surface and distilled water in conventional water treatment processes, J. Environ. Eng., 128. 253-260.   DOI
12 Ahn, J.C. (2016). Development of analysis and DB on concern of emerging contaminants in the waterworks, Korea Environmental Industry & Technology Institute, The ministry of Environment.
13 Ahn, J.C., Jeng, K.J., Kwon, H.S., An, C.H., Kim, J.I., Youn, U.H., Lee, I.J., Son, B.Y., Moon, B.R. and Lee, S.W. (2016). Pharmaceuticals in drinking-water, Seoul Water Institute, 9.
14 Bendz, D., Paxdus, N.A., Ginn. T.R. and Loge, F.J. (2005). Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden, J. Hazard. Mater., 122, 195-204.   DOI
15 Buxton, G.V., Greenstock, C.L., Helman, W.P. and Ross, A.B. (1988). Critical review of rate constants for reactions of hydrated electrons, hydrogen atoms and hydroxyl radicals in aqueous solution, J. Phys. Chem., 17(2), 513-886.
16 Hofman-Caris C.H.M., Harmsen D.J.H., Wols B.A., Beerendonk E.F. and Keltjens L.L.M. (2015a). Determination of reaction rate constants in a collimated beam setup: the effect of water quality and water depth, Ozone : Sci. Eng., 37(2), 134-142.   DOI
17 Huber, M.M., Canonica, S., Park, G.Y. and Gunten, U.V. (2003). Oxidation of pharmaceuticals during ozonation and advanced oxidation processes, Environ. Sci. Technol., 37. 1016-1024.   DOI
18 Huber, M.M, Korhonen, S., Ternes, T.A. and Gunten U. (2005). Oxidation of pharmaceuticals during water treatment with chlorine dioxide, Water Res., 39, 3607-3617.   DOI